# Loop Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/loop-medical

- Industry: Medical Devices & Equipment
- Headquarters: Lausanne, Switzerland
- Website: www.loop-medical.com
- Total disclosed funding: $6.4M
- Latest round: Series A (Oct 14, 2021)
- Investors on record: 2

## About

Loop Medical SA develops innovative blood collection solutions aimed at enhancing the patient and healthcare professional experience. Their products streamline blood sampling for improved efficiency and convenience.Loop Medical SA, founded in 2017 and headquartered in Lausanne, Switzerland, specializes in advanced blood collection devices. The CEO and founder, Arthur Queval, has a background in health technology, which he leveraged to establish the company. Loop Medical successfully completed its Series A funding round in October 2021, raising USD 6.4 mn from investors including SARSTEDT AG & CO. KG and Casdin Capital, marking a significant milestone in its growth.Loop Medical specializes in innovative blood collection solutions designed to simplify the process for both patients and healthcare professionals. Their flagship products, Onflow and Maxflow, allow for the collection of blood samples in a manner that is both timely and user-friendly. Onflow can collect up to 1.5 ml of blood in 2-6 minutes, while Maxflow enables the collection of up to 4 ml in 4-7 minutes. These devices facilitate annual blood tests through a single easy draw, integrating seamlessly into patients' lifestyles and encouraging regular health monitoring. The primary end users include patients of all ages requiring blood tests, as well as healthcare providers who benefit from the streamlined collection process. Loop Medical targets advanced healthcare markets in Europe and North America.Loop Medical's revenue structure is based on direct sales of its blood collection devices, primarily targeting healthcare institutions and professionals. The company engages in business-to-business transactions, supplying its products to hospitals, clinics, and diagnostic laboratories. The pricing model for their offerings is structured around direct sales agreements, where healthcare providers purchase the devices outright or through negotiated contracts tailored to their specific needs. Loop Medical's products are positioned as premium solutions in the market, emphasizing quality and patient experience, generating revenue from sales of devices like Onflow and Maxflow as well as potential partnerships with healthcare facilities that include training and support services.Loop Medical plans to utilize its Series A funding of USD 6.4 mn from October 2021 to support U.S. FDA clearance and the manufacturing of its blood collection devices. The company is also focused on expanding its market presence in North America and Europe, with strategic initiatives aimed at enhancing its product offerings and entering new markets by the end of 2023.

## Funding rounds

- Series A, Oct 14, 2021, $6.4M — Casdin Capital, SARSTEDT AG & CO. KG

## Investors

- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A
- SARSTEDT AG & CO. KG — Series A